awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37357304-59C969BF-2E1A-49C6-872A-21AC0188B57E
Q37357304-59C969BF-2E1A-49C6-872A-21AC0188B57E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37357304-59C969BF-2E1A-49C6-872A-21AC0188B57E
New avenues for second-line treatment of metastatic non-small-cell lung cancer.
P2860
Q37357304-59C969BF-2E1A-49C6-872A-21AC0188B57E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37357304-59C969BF-2E1A-49C6-872A-21AC0188B57E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
437219962bf4334acf8ab0d59f0f186a5692ae5b
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).